跳至主要内容
临床试验/NCT07135232
NCT07135232招募中不适用

The Effects of Resistance Training and a Sarmentosin - L-theanine Supplement on Perimenopausal Symptoms and Musculoskeletal Health: A Randomised Controlled Trial

Leeds Beckett University1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2026年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
72
试验地点
1
主要终点
Depressive Symptom Score at week 4

研究概览

简要总结

The aim of this clinical trial is to determine if resistance training and a newly developed plant-based nutritional supplement can improve the symptoms and musculoskeletal health of perimenopausal women.

The main questions it aims to evaluate are:

  1. Can resistance training and the nutritional supplement - both independently and in combination - improve perimenopausal symptoms (e.g. cognition, mood, sleep) and musculoskeletal outcomes (e.g. strength, muscle mass)?
  2. What are the acute effects of the nutritional supplement on cognitive function and mood in perimenopausal women, and is this response altered following long-term intake (12 weeks)?
  3. What mechanisms may be contributing to the results?

Participants will be split into four groups to allow the researchers to answer the above questions. These are:

  1. The nutritional supplement + resistance training
  2. The nutritional supplement only
  3. The placebo supplement (A look alike capsule that contains no active ingredients) and resistance training
  4. The Placebo supplement only.

Participants will:

  • Take their allocated supplement daily and perform home-based strength exercise 3 times per week (for exercise groups), for 12 weeks.
  • Attend the laboratory at the beginning and end of the 12 weeks to assess cognitive function and mood following acute intake of the supplement.
  • Attend the laboratory every 4 weeks during the 12 week period, for assessment of cognitive function, symptom severity and muscle health.
  • Provide a blood sample at each visit for assessment of mechanistic pathways.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

盲法说明

Masking will only be applied to supplement allocation. All parties will be aware of their exercise allocation.

入排标准

年龄范围
40 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Perimenopausal women between 40 - 55 years
  • Not currently engaging in consistent structured resistance training (defined as >3 resistance training sessions per week for 4 consecutive weeks, in the past six months).
  • Not on any HRT or hormonal contraception for at least one year before initiation of the study.
  • Able to attend laboratory visits and commit to the intervention schedule for 6 months.
  • Willing to provide blood samples
  • Not regularly consuming any dietary supplements containing concentrated sarmentosin, L-theanine or other compounds that may interfere with the study intervention.
  • Willing to limit dietary intake of Sarmentosin (e.g. Blackcurrant) and L-theanine (e.g. green tea/ black tea).
  • Willing and able to provide written informed consent

排除标准

  • Diagnosed cardiovascular disease (CVD), uncontrolled hypertension (>160/100 mmHg), or other conditions that prevent safe exercise participation.
  • Clinically diagnosed mental health disorders (e.g., bipolar disorder, schizophrenia, severe depression requiring medication adjustment within the last 6 months).
  • Neurological conditions affecting cognitive function (e.g., Parkinson's disease, multiple sclerosis, epilepsy).
  • Endocrine disorders that could impact hormonal fluctuations or metabolism (e.g., uncontrolled diabetes, thyroid dysfunction).
  • History of major musculoskeletal injuries (e.g., fractures, joint replacement) within the past 6 months
  • Regular use of medications that could interfere with study outcomes, including antidepressants, corticosteroids, beta-blockers.
  • Obesity (BMI >30 or for South Asian Ethinicity BMI> 27.5)
  • Food allergy or intolerance to study products.
  • Use of illicit drugs.
  • Alcohol intake exceeding the government guidelines of 14 standard units per week (Equivalent of 6 standard drinks).
  • Pregnant or planning to conceive during the trial.
  • High habitual caffeine intake (>400 mg/day which is approximately 4-5 cups of coffee)

研究组 & 干预措施

Placebo Supplement Only

Placebo Comparator

Two placebo capsules to be consumed by participants daily

干预措施: Placebo Supplement (Dietary Supplement)

Placebo Supplement and Resistance Training

Experimental

Participants will consume two placebo supplements daily, and perform structured resistance training three times per week.

干预措施: Resistance Training (Other)

Placebo Supplement and Resistance Training

Experimental

Participants will consume two placebo supplements daily, and perform structured resistance training three times per week.

干预措施: Placebo Supplement (Dietary Supplement)

Active Supplement Only

Experimental

Participants will consume two capsules of the Sarmentosin - L-theanine supplement daily.

干预措施: Sarmentosin - L- theanine (Dietary Supplement)

Active Supplement and Resistance Training

Experimental

Participants will consume two capsules of the Sarmentosin - L-theanine supplement daily and perform structured resistance training three times per week.

干预措施: Resistance Training (Other)

Active Supplement and Resistance Training

Experimental

Participants will consume two capsules of the Sarmentosin - L-theanine supplement daily and perform structured resistance training three times per week.

干预措施: Sarmentosin - L- theanine (Dietary Supplement)

结局指标

主要结局

Depressive Symptom Score at week 4

时间窗: Week 4

Assessed using the depressive sub-scale of the Depression, Anxiety and stress scale - 21 items. Assessed on a scale from 0 - 3 over 7 questions, with a maximum score of 42. Higher scores indicate more severe depressive symptoms.

Depressive Symptom Score at Week 8

时间窗: Week 8

Assessed using the depressive sub-scale of the Depression, Anxiety and stress scale - 21 items. Assessed on a scale from 0 - 3 over 7 questions, with a maximum score of 42. Higher scores indicate more severe depressive symptoms.

Change in Sustained Attention Pre- to Post-Supplement Intake at Week 1

时间窗: Pre- to 1 hour post- supplement intake at week 1 of the intervention.

Assessed as the signal detection measure of a subject's sensitivity to the target sequence (A') during the Cambridge Neuropsychological Test Automated Battery rapid visual information processing test.

Change in Sustained Attention Pre- to Post-Supplement Intake at Week 12

时间窗: Pre- to 1 hour post- supplement intake at week 12 of the intervention.

Assessed as the signal detection measure of a subject's sensitivity to the target sequence (A') during the Cambridge Neuropsychological Test Automated Battery rapid visual information processing test.

Depressive Symptom Score at Week 12

时间窗: Week 12

Assessed using the depressive sub-scale of the Depression, Anxiety and stress scale - 21 items. Assessed on a scale from 0 - 3 over 7 questions, with a maximum score of 42. Higher scores indicate more severe depressive symptoms.

次要结局

  • Verbal Episodic Memory Performance at Week 12(Week 12)
  • Verbal Episodic Memory Performance at Week 8(Week 8)
  • Verbal Episodic Memory Performance at Week 4(Week 4)
  • Spatial Planning and Working Memory Performance at Week 12(Week 12)
  • Working Memory Performance at Week 4(Week 4)
  • Working Memory Performance at Week 8(Week 8)
  • Working Memory Performance at Week 12(Week 12)
  • Spatial Planning and Working Memory Performance at Week 4(Week 4)
  • Spatial Planning and Working Memory Performance at week 8(Week 8)
  • Sustained Attention Performance at Week 4(Week 4)
  • Sustained Attention Performance at Week 12(Week 12)
  • Sustained Attention Performance at week 8(Week 8)
  • Subjective Memory Complaints at Week 4(Week 4)
  • Subjective Memory Complaints at Week 8(Week 8)
  • Subjective Memory Complaints at Week 12(Week 12)
  • Self-reported Sleep Quality at Week 4(Week 4)
  • Self-reported Sleep Quality at Week 8(Week 8)
  • Self-reported Sleep Quality at Week 12(Week 12)
  • Self-reported Hot Flash Severity and Frequency at Week 4(Week 4)
  • Self-reported Hot Flash Severity and Frequency at Week 8(Week 8)
  • Self-reported Hot Flash Severity and Frequency at Week 12(Week 12)
  • Anxiety Symptoms at Week 4(Week 4)
  • Anxiety Symptoms at Week 8(Week 8)
  • Anxiety Symptoms at Week 12(Week 12)
  • Stress symptoms at Week 4(Week 4)
  • Stress Symptoms at Week 8(Week 8)
  • Stress Symptoms at Week 12(Week 12)
  • Quality of Life Score at Week 4(Week 4)
  • Quality of Life Score at Week 8(Week 8)
  • Quality of Life Score at Week 12(Week 12)
  • Change in Handgrip Strength from baseline to Week 12(Baseline and Week 12)
  • change in Leg Extensor Submaximal Strength from baseline to Week 12(Baseline and Week 12)
  • Change in Isometric Mid-thigh Pull Strength from baseline to Week 12(Baseline and Week 12)
  • Change in the Number of Reps Completed in the 30 Second Sit-to-stand Test from baseline to week 12(baseline and Week 12)
  • Change in Appendicular Lean Mass from baseline to Week 12(Baseline and Week 12)
  • Felt-affect Visual Analogue score at week 4(Week 4)
  • Felt-affect Visual Analogue score at week 8(Week 8)
  • Felt-affect Visual Analogue score at week 12(Week 12)
  • Exercise Enjoyment at week 1(Week 1)
  • Exercise Enjoyment at week 4(Week 4)
  • Exercise Enjoyment at week 8(Week 8)
  • Exercise Enjoyment at week 12(Week 12)
  • Change in Verbal Episodic Memory Performance from Pre- to Post-Supplement Intake in Week 1.(Pre- to 1 hour post- supplement intake in week 1)
  • Change In Working Memory Performance From Pre- to Post-Supplement Intake in Week 12.(Pre- to 1 hour post- supplement intake in week 12)
  • Change in Verbal Episodic Memory Performance From Pre- to Post-Supplement Intake in Week 12(Pre- to 1 hour post- supplement intake in week 12)
  • Change in Working Memory Performance From Pre- to Post-Supplement Intake in Week 1(Pre- to 1 hour post- supplement intake in week 1)
  • Change in Spatial Planning and Working Memory Performance From Pre- to Post-Supplement Intake in Week 1.(Pre- to 1 hour post- supplement intake in week 12)
  • Change in Mood State From Pre- to Post- Supplement Intake in week 1(Pre- to 1 hour post- supplement intake in week 1.)
  • Change in total body fat percentage from baseline to Week 12(Baseline and Week 12)
  • Change in Mood State From Pre- to Post- Supplement Intake in Week 12(Pre- to 1 hour post- supplement intake in week 12)
  • Change in Spatial Planning and Working Memory Performance From Pre- to Post-Supplement Intake in Week 1.(Pre- to 1 hour post- supplement intake in week 1.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Harriet Cannell

Doctoral Researcher

Leeds Beckett University

研究点 (1)

Loading locations...

相似试验